Caricamento...
Exploring the mechanism of resistance to sorafenib in two hepatocellular carcinoma cell lines
Sorafenib has long been the only approved systemic therapy for advanced hepatocellular carcinoma (HCC), but most patients show primary or acquired drug resistance. In the present study, RNA was extracted from sorafenib-resistant and -sensitive clones of the HCC cell lines HepG2 and Huh7. Protein-pro...
Salvato in:
| Pubblicato in: | Aging (Albany NY) |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Impact Journals
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7762478/ https://ncbi.nlm.nih.gov/pubmed/33234725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.104195 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|